Get Started

CARM

PINK Carisma Therapeutics, Inc.
Oct 27, 2026 · 1:08 AM ET EOD Market Closed

$0.0003 ↑ +0.0001 (+50.00%) Trading Up from the previous close of $0.0002, and at the day’s high of $0.0003

YTD change
-99.30%
vs 20-day SMA
-79.66%
vs 200-day SMA
-98.20%

Price ranges

Previous day
$0.0002 $0.0002
open $0.0002 close $0.0002
+$0.0000 (+0.00%)
Today
$0.0003 $0.0003
open $0.0003 now $0.0003
+$0.0000 (+0.00%)
Past week
$0.0002 $0.0200
from $0.0200 now $0.0003
-$0.0197 (-98.50%)
Past month
$0.0002 $0.0200
from $0.0007 now $0.0003
-$0.0004 (-57.14%)
This year
$0.0001 $0.0500
from $0.0430 now $0.0003
-$0.0427 (-99.30%)

Price & Performance

-0.00 (-40.00%) / 6M

$-0.0016$0.0066$0.0148$0.0230Apr 27Jul 24Oct 26

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 100.0% away from all-time highs of $9.7662
  • CARM is down 99% since the beginning of the year
  • CARM is down 99% over the past 12 months
  • CARM is down 57% over the past 1 month
  • 0% of all CARM investors are betting against CARM

CARM reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -99.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-2006610.0
Beta -35.68

Balance sheet & scale

Income$8.0K
Revenue$52.6M
Cash$2.8M
Debt$762.0
Income / Debt 10.55×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $12.6K

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $444.63 +1.22%
MRNA Moderna, Inc. $198.85 -0.62%
RVMD Revolution Medicines, Inc. $183.90 -1.65%
ROIV Roivant Sciences Ltd. $36.05 -1.21%
BNTX BioNTech SE Sponsored ADR $86.86 -1.42%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.